The U.S. Food and Drug Administration is set to release guidelines for biosimilar drugs by year’s end. The shape of those guidelines will determine whether the new drugs are a competitive threat or a potential market opportunity for Amgen, the world’s largest biotechnology firm and the biggest private-sector employer in Ventura County. Biosimilars are the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
